Controlled Substances Act

Controlled Substances Act
source
Shorttitle	Controlled Substances Act
Othershorttitles	CSA
Longtitle	An Act to amend the Public Health Service Act and other laws to provide increased research into, and prevention of, drug abuse and drug dependence; to provide for treatment and rehabilitation of drug abusers and drug dependent persons; and to strengthen existing law enforcement authority in the field of drug abuse.
Enacted by	91st
Effective date	May 1, 1971
Public law	91-513
Statutes at large	84 Stat. 1236
Titles amended	21 U.S.C.: Food and Drugs
Sections created	21 U.S.C. ch. 13 § 801 et seq.
Introducedin	House
Introducedby	Harley O. Staggers
Committees	House Interstate and Foreign Commerce

Controlled Substances Act. The Controlled Substances Act is the foundational statute establishing the federal United States drug policy, creating a comprehensive framework for the regulation of certain drugs and substances. Enacted as Title II of the Comprehensive Drug Abuse Prevention and Control Act of 1970, it consolidated numerous existing laws and established a unified system of classification and control. The law is administered by the Drug Enforcement Administration and significantly shapes criminal justice, public health, and international policy.

Overview and legislative history

The legislation was championed by the Richard Nixon administration, with key figures like Attorney General John N. Mitchell and Congressman Harley O. Staggers playing pivotal roles. It was developed in response to growing public concern over drug use and the need to replace a patchwork of laws, such as the Harrison Narcotics Tax Act and the Marihuana Tax Act of 1937. The act was influenced by international treaty obligations under the Single Convention on Narcotic Drugs. Following hearings in the United States House of Representatives and the United States Senate, it was signed into law on October 27, 1970, by President Nixon.

Schedules of controlled substances

The core of the regulatory scheme is the classification of drugs into five schedules, based on their accepted medical use, potential for abuse, and safety or dependence liability. Schedule I substances, such as heroin, LSD, and marijuana, are deemed to have no accepted medical use and a high abuse potential. Schedules II through V contain substances with recognized medical applications but varying abuse potentials, including cocaine, methamphetamine, oxycodone, and alprazolam. The authority to add, remove, or reschedule substances rests with the Attorney General of the United States, acting on recommendations from the Department of Health and Human Services.

Enforcement and regulatory agencies

Primary enforcement authority is vested in the Drug Enforcement Administration, a bureau of the United States Department of Justice created in 1973. The DEA conducts investigations, oversees regulatory compliance for manufacturers and distributors, and maintains the national system for tracking controlled substances. The Food and Drug Administration provides scientific and medical evaluations for scheduling decisions. Other agencies, including the Federal Bureau of Investigation, U.S. Customs and Border Protection, and the Internal Revenue Service, often collaborate on complex investigations targeting organizations like the Medellín Cartel or operations such as Project Cassandra.

Legal and social impact

The act has profoundly influenced the American legal landscape, leading to landmark Supreme Court cases like Gonzales v. Raich, which affirmed federal power to regulate intrastate marijuana cultivation. Its provisions have been central to major law enforcement initiatives, including the War on Drugs declared by President Ronald Reagan. Critics, including organizations like the American Civil Liberties Union and scholars, argue it has contributed to mass incarceration, racial disparities in sentencing, and hindered medical research, particularly concerning psilocybin and MDMA. The act also serves as the basis for U.S. positions in international forums like the United Nations Commission on Narcotic Drugs.

Amendments and related legislation

Numerous laws have amended or expanded its provisions. The Psychotropic Substances Act of 1978 implemented the Convention on Psychotropic Substances. The Anti-Drug Abuse Act of 1986 established mandatory minimum sentences, while the Chemical Diversion and Trafficking Act targeted precursor chemicals. The Ryan Haight Online Pharmacy Consumer Protection Act of 2008 addressed internet prescriptions. More recently, the Agriculture Improvement Act of 2018 removed low-THC hemp from the definition of marijuana under the act, and ongoing legislative efforts, such as the MORE Act, seek broader reforms to its cannabis provisions.

Category:United States federal criminal legislation Category:1970 in American law Category:Drug control law in the United States